nmr drug design

NMR in the World of Fragmented Drug Design

NMR in the World of Fragment Based Drug Design – through both the Ligand and Protein observe lenses

On October 26, 2023 the IVAN Users Group hosted a meeting on NMR in the World of Fragmented Drug Design. The panel was lead by Daneen Angwin-Kaerner of Loxo@Lilly, and presentations were done by Andrew Namanja of Abbvie Inc. and Ben Davis of Vernalis Research. NMR has evolved into a[…]

Read More »